160 related articles for article (PubMed ID: 19911811)
1. Rapid and label-free detection of breast cancer biomarker CA15-3 in clinical human serum samples with optofluidic ring resonator sensors.
Zhu H; Dale PS; Caldwell CW; Fan X
Anal Chem; 2009 Dec; 81(24):9858-65. PubMed ID: 19911811
[TBL] [Abstract][Full Text] [Related]
2. Novel automated flow-based immunosensor for real-time measurement of the breast cancer biomarker CA15-3 in serum.
Darwish IA; Wani TA; Khalil NY; Blake DA
Talanta; 2012 Aug; 97():499-504. PubMed ID: 22841114
[TBL] [Abstract][Full Text] [Related]
3. Combined measurement of serum sialyl Lewis X with serum CA15-3 in breast cancer patients.
Kurebayashi J; Nomura T; Hirono M; Okubo S; Udagawa K; Shiiki S; Ikeda M; Nakashima K; Tanaka K; Sonoo H
Jpn J Clin Oncol; 2006 Mar; 36(3):150-3. PubMed ID: 16520359
[TBL] [Abstract][Full Text] [Related]
4. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K
Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of serum HER2 and CA 15-3 at the time of diagnosis of metastatic breast cancer.
Fehm T; Jäger W; Krämer S; Sohn C; Solomayer E; Wallwiener D; Gebauer G
Anticancer Res; 2004; 24(3b):1987-92. PubMed ID: 15274389
[TBL] [Abstract][Full Text] [Related]
6. Opto-fluidic micro-ring resonator for sensitive label-free viral detection.
Zhu H; White IM; Suter JD; Zourob M; Fan X
Analyst; 2008 Mar; 133(3):356-60. PubMed ID: 18299750
[TBL] [Abstract][Full Text] [Related]
7. Phage-based label-free biomolecule detection in an opto-fluidic ring resonator.
Zhu H; White IM; Suter JD; Fan X
Biosens Bioelectron; 2008 Nov; 24(3):461-6. PubMed ID: 18550355
[TBL] [Abstract][Full Text] [Related]
8. Direct label-free electrical immunodetection in human serum using a flow-through-apparatus approach with integrated field-effect transistors.
Kim A; Ah CS; Park CW; Yang JH; Kim T; Ahn CG; Park SH; Sung GY
Biosens Bioelectron; 2010 Mar; 25(7):1767-73. PubMed ID: 20093001
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of SPR and ELISA methods based on analysis of CD166/ALCAM levels in cancer and control human sera.
Vaisocherová H; Faca VM; Taylor AD; Hanash S; Jiang S
Biosens Bioelectron; 2009 Mar; 24(7):2143-8. PubMed ID: 19157844
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of pre-operative serum CA 15.3 levels in breast cancer.
Martín A; Corte MD; Alvarez AM; Rodriguez JC; Andicoechea A; Bongera M; Junquera S; Pidal D; Allende T; Muñiz JL; Vizoso F
Anticancer Res; 2006; 26(5B):3965-71. PubMed ID: 17094428
[TBL] [Abstract][Full Text] [Related]
11. [Immunoradiometric assay of tumor marker CA15-3 and its clinical application].
Chen Z; Fan Z; Yang J
Zhonghua Zhong Liu Za Zhi; 1998 Mar; 20(2):125-8. PubMed ID: 10920962
[TBL] [Abstract][Full Text] [Related]
12. Tumor markers in breast cancer monitoring should be scheduled according to initial stage and follow-up time: a prospective study on 859 patients.
Gion M; Peloso L; Mione R; Vignati G; Fortunato A; Saracchini S; Biasioli R; Gulisano M; Cappelli G
Cancer J; 2001; 7(3):181-90. PubMed ID: 11419026
[TBL] [Abstract][Full Text] [Related]
13. A protein chip system for parallel analysis of multi-tumor markers and its application in cancer detection.
Sun Z; Fu X; Zhang L; Yang X; Liu F; Hu G
Anticancer Res; 2004; 24(2C):1159-65. PubMed ID: 15154641
[TBL] [Abstract][Full Text] [Related]
14. Development of a sensitive detection method of cancer biomarkers in human serum (75%) using a quartz crystal microbalance sensor and nanoparticles amplification system.
Uludağ Y; Tothill IE
Talanta; 2010 Jun; 82(1):277-82. PubMed ID: 20685467
[TBL] [Abstract][Full Text] [Related]
15. [Prevalence of elevated serum CA 15-3 at time of metastatic relapse of breast cancer and correlation with hormone receptor status].
Bensouda Y; André F; Boulet T; Al-Ghuzlan A; Conforti R; Troalen F; Bourgier C; Errihani H; Spielmann M; Delaloge S
Bull Cancer; 2009 Oct; 96(10):923-8. PubMed ID: 19696005
[TBL] [Abstract][Full Text] [Related]
16. The HCCR oncoprotein as a biomarker for human breast cancer.
Jung SS; Park HS; Lee IJ; Namkoong H; Shin SM; Cho GW; Ha SA; Park YG; Lee YS; Ko J; Kim JW
Clin Cancer Res; 2005 Nov; 11(21):7700-8. PubMed ID: 16278390
[TBL] [Abstract][Full Text] [Related]
17. A nanochannel/nanoparticle-based filtering and sensing platform for direct detection of a cancer biomarker in blood.
de la Escosura-Muñiz A; Merkoçi A
Small; 2011 Mar; 7(5):675-82. PubMed ID: 21294272
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of serum KL-6, a mucin-like glycoprotein, as a tumor marker for breast cancer.
Ogawa Y; Ishikawa T; Ikeda K; Nakata B; Sawada T; Ogisawa K; Kato Y; Hirakawa K
Clin Cancer Res; 2000 Oct; 6(10):4069-72. PubMed ID: 11051258
[TBL] [Abstract][Full Text] [Related]
19. Enhanced gold nanoparticle based ELISA for a breast cancer biomarker.
Ambrosi A; Airò F; Merkoçi A
Anal Chem; 2010 Feb; 82(3):1151-6. PubMed ID: 20043655
[TBL] [Abstract][Full Text] [Related]
20. Direct detection of carcinoembryonic antigen autoantibodies in clinical human serum samples using a surface plasmon resonance sensor.
Ladd J; Lu H; Taylor AD; Goodell V; Disis ML; Jiang S
Colloids Surf B Biointerfaces; 2009 Apr; 70(1):1-6. PubMed ID: 19157807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
